Unanswered questions about higher potency statins and the risk of new diabetesBMJ 2014; 349 doi: http://dx.doi.org/10.1136/bmj.g4876 (Published 30 July 2014) Cite this as: BMJ 2014;349:g4876
- J J Brugts, cardiologist1
- 1Department of Cardiogy, Erasmus MC Thoraxcenter, Rotterdam, Netherlands
Dormuth and colleagues conclude that the use of higher potency statins is associated with a moderate increase in new onset diabetes compared with lower potency drugs.1
I have several comments on this article.
Firstly, the authors categorised simvastatin 40 mg as a higher potency statin. This is one of the most commonly prescribed statins and in my opinion not one …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial